Loading clinical trials...
Loading clinical trials...
The primary goal of this study is to examine whether recurrence of HPV-associated OPSCC can be predicted by two factors: 1) mutations in genes called TRAF3 and CYLD, and 2) measurements of circulating...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
NCT06980038 · Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, and more
NCT05541016 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, and more
NCT07565740 · HPV-positive Oropharyngeal Squamous Cell Carcinoma
NCT07040956 · Head and Neck Squamous Cell Carcinoma, Low-dose Radiotherapy, and more
NCT05268614 · Oropharyngeal Squamous Cell Carcinoma
Mayo Clinic
Rochester, Minnesota
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Trident Medical Center (HCA Healthcare )
North Charleston, South Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions